BioPortUSA
08 Aug

Bio-M invites BioPortUSA CEO to speak about Market Access U.S.A.

#

BioM BioPortUSA

Bio-M, Germany’s largest Biotech Accelerator has invited a team from BioPortUSA to talk about the impact that the Inflation Reduction Act and the DSCSA Compliance has had on drug discovery.

The event will take place on September 26, 2023 from 3-5pm Central European Time and is a hybrid setting allowing those who wish to meet in person to participate as well as those who want to attend virtually.

The United States is recognized globally as a leading innovator and research center in biotechnology. At the same time, the U.S. healthcare market is constantly changing and offers companies a wide range of opportunities as well as challenges. Currently, not only the Drug Supply Chain Security Act with its specific requirements and regulations has to be considered, but also the Inflation Reduction Act with its significant impact on drug development and research.


In our webseminar, co-organized with BioPortUSA, we are especially interested in giving you the opportunity to learn from leading experts and industry insiders, get insider information and ask your specific questions. We believe the webinar will provide valuable insights into the latest developments, technologies and best practices in the U.S. biotechnology industry.

Event Details

This event is available to participants attending remotely or in person at BioM headquarters.

Online

Details to be published here.

In Person

BioM Biotech Cluster Development GmbH
Am Klopferspitz 19 a
(IZB West II, 3. OG)
82152 Martinsried/München 

Discussion topics include:

  • Changes and opportunities of the US healthcare market
  • Information on what is the Drug Supply Chain Security Act (DSCSA) and what requirements are important in 2023
  • Overview of how the Inflation Reduction Act (IRA) is impacting drug discovery

The webseminar Navigating the U.S. Healthcare Market - Insights into DSCSA Compliance and IRA's Impact on Drug Discovery provides valuable knowledge into the U.S. market, exciting insights into current developments such as DSCSA and IRA, and a unique opportunity to interact with industry experts.

In the webseminar, co-organized with BioM, we are especially interested in providing the opportunity to learn from leading experts and industry insiders, get insider information and ask your specific questions. We believe the webinar will provide valuable insights into the latest developments, technologies and best practices in the U.S. biotechnology industry.

Learn More at BioM Online